Literature DB >> 16934762

Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics.

Wim Vanden Berghe1, Matladi N Ndlovu, Ruben Hoya-Arias, Nathalie Dijsselbloem, Sarah Gerlo, Guy Haegeman.   

Abstract

Controlled expression of cytokine genes is an essential component of an immune response and is crucial for homeostasis. In order to generate an appropriate response to an infectious condition, the type of cytokine, as well as the cell type, dose range and the kinetics of its expression are of critical importance. The nuclear factor-kappaB (NF-kappaB) family of transcription factors has a crucial role in rapid responses to stress and pathogens (innate immunity), as well as in development and differentiation of immune cells (acquired immunity). Although quite a number of genes contain NF-kappaB-responsive elements in their regulatory regions, their expression pattern can significantly vary from both a kinetic and quantitative point of view, reflecting the impact of environmental and differentiative cues. At the transcription level, selectivity is conferred by the expression of specific NF-kappaB subunits and their respective posttranslational modifications, and by combinatorial interactions between NF-kappaB and other transcription factors and coactivators, that form specific enhanceosome complexes in association with particular promoters. These enhanceosome complexes represent another level of signaling integration, whereby the activities of multiple upstream pathways converge to impress a distinct pattern of gene expression upon the NF-kappaB-dependent transcriptional network. Today, several pieces of evidence suggest that the chromatin structure and epigenetic settings are the ultimate integration sites of both environmental and differentiative inputs, determining proper expression of each NF-kappaB-dependent gene. We will therefore discuss in this review the multilayered interplay of NF-kappaB signaling and epigenome dynamics, in achieving appropriate gene expression responses and transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934762     DOI: 10.1016/j.bcp.2006.07.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  38 in total

Review 1.  Epigenetic regulation in alcoholic liver disease.

Authors:  Pranoti Mandrekar
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling.

Authors:  Douglas J Kominsky; Simon Keely; Christopher F MacManus; Louise E Glover; Melanie Scully; Colm B Collins; Brittelle E Bowers; Eric L Campbell; Sean P Colgan
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 3.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

Review 4.  The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.

Authors:  R Romero; J Espinoza; F Gotsch; J P Kusanovic; L A Friel; O Erez; S Mazaki-Tovi; N G Than; S Hassan; G Tromp
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

5.  Cognition-Enhancing Vagus Nerve Stimulation Alters the Epigenetic Landscape.

Authors:  Teresa H Sanders; Joseph Weiss; Luke Hogewood; Lan Chen; Casey Paton; Rebekah L McMahan; J David Sweatt
Journal:  J Neurosci       Date:  2019-02-25       Impact factor: 6.167

Review 6.  The environmental health of Latino children.

Authors:  Olivia Carter-Pokras; Ruth E Zambrana; Carolyn F Poppell; Laura A Logie; Rafael Guerrero-Preston
Journal:  J Pediatr Health Care       Date:  2007 Sep-Oct       Impact factor: 1.812

Review 7.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

8.  Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease.

Authors:  Y Tang; T Li; J Li; J Yang; H Liu; X J Zhang; W Le
Journal:  Cell Death Differ       Date:  2013-11-08       Impact factor: 15.828

9.  Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols.

Authors:  Wipob Suttana; Samlee Mankhetkorn; Wilart Poompimon; Ajay Palagani; Sergey Zhokhov; Sarah Gerlo; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cancer       Date:  2010-05-03       Impact factor: 27.401

10.  Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon.

Authors:  Rita Moreno; Jürgen-Markus Sobotzik; Christian Schultz; M Lienhard Schmitz
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.